Anjana Narain

Executive Vice President and General Manager, Seqirus

Anjana Narain

Anjana Narain was appointed Executive Vice President and General Manager of Seqirus in August 2019.  With more than 25 years of experience in the pharmaceutical industry, Anjana is a global vaccines leader who has lived and worked across three continents and is a recognized champion of inclusion and diversity. Prior to joining Seqirus, Anjana spent nine years at GSK leading major businesses, including global influenza commercialization where she was responsible for the development, manufacturing and commercialization of seasonal, pandemic and cell culture programs. She started her career in market research and pharmaceutical sales at Bayer, Inc, (previously Miles Inc) USA, then at Merck & Co’s US pharma and global vaccines organizations. Anjana holds a BA from RG College in India and an MBA from the University of New Haven, and is a graduate of the General Management Program at Harvard Business School in Boston.

Leading the Way on Rare & Serious Diseases

We are committed to saving and improving the lives of people with rare and serious diseases worldwide.

Learn More
Job Opportunities

Join us and make history with the brightest, most passionate people from every discipline.

Learn More
Investing in CSL

CSL is CSL Behring's parent company. Visit CSL.com to learn more about being a shareholder.

Visit CSL.com/Investors